| |
| | NIP: Shortages/Vaccines PCV7 reinstate 3rd dose |
 | | The fourth dose should still be deferred for healthy children until further production and supply data demonstrate convincingly that a 4-dose schedule can be sustained. |
 | | The full, 4-dose, series should continue to be given to children at increased risk for pneumococcal disease because of certain chronic conditions (e.g., sickle cell disease, anatomic asplenia, chronic heart or lung disease, diabetes, cerebrospinal fluid leak, cochlear implant, or an immunocompromising condition). |
 | | When the shortage is completely resolved, providers should consider administering a single dose to unvaccinated, healthy children 24-59 months old with priority to children 24-35 months old, children of African-American descent, children of American-Indian descent but not otherwise identified as high risk‡, and children who attend group day care centers. |
| www.cdc.gov /nip/news/shortages/pcv7-shortage-faqs-7-8-04.htm (807 words) |
|